Ashton Thomas Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5M Buy
+4,324
New +$5.1M 0.53% 42
2026
Q2
– Sell
-3,359
Closed -$3.09M – 467
2026
Q1
$3.09M Buy
+3,359
New +$3.41M 0.39% 60
2025
Q4
– Sell
-2,721
Closed -$2.07M – 385
2025
Q3
$2.07M Buy
+2,721
New +$2.02M 0.29% 88
2024
Q4
– Sell
-3,782
Closed -$3.35M – 814
2024
Q3
$3.35M Buy
3,782
+1,103
+41% +$992K 0.65% 33
2024
Q2
$2.5M Buy
+2,679
New +$2.14M 0.6% 43

Other funds holding LLY

Ashton Thomas Securities's LLY Position: Q3 2026 in Review

Ashton Thomas Securities opened a new position in Eli Lilly (LLY) in Q3 2026: 4,324 shares worth $5M. The stake represents 0.53% of the portfolio and ranks #42 among its holdings. This is a return to the name: Ashton Thomas Securities previously reported a position in LLY as recently as Q1 2026.

Ashton Thomas Securities first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ashton Thomas Securities held 4,324 shares of Eli Lilly worth $5M as of Q3 2026.
  • Eli Lilly was a new Ashton Thomas Securities position in Q3 2026.
  • Eli Lilly made up 0.53% of Ashton Thomas Securities's portfolio in Q3 2026, its #42 holding.
  • Ashton Thomas Securities first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ashton Thomas Securities's 13F filing for Q3 2026, filed 26 Oct 2026.